Meta tags:
description=;

Headings (most frequently used words):

nephjc, visual, about, news, upcoming, nephjcs, recent, discussions, abstracts, resumen, on, instagram, what, you, need, to, know, statistics, the, patient, voice, tweetorials, posts, introducing, shorts, subscribe,

Text of the page (most frequently used words):
2026 (139), the (137), more (91), read (86), 2025 (66), and (57), august (48), trial (35), #nephjc (32), this (32), will (28), discuss (27), week (26), with (25), september (24), kidney (24), july (24), november (21), ckd (17), patients (15), march (15), may (14), visual (13), april (13), that (13), december (12), january (12), are (12), june (12), from (11), for (11), nephrology (10), trials (10), use (10), can (10), 2021 (10), 2023 (10), discussion (10), what (9), credit (9), october (9), twitter (9), club (9), february (9), diabetic (9), our (8), find (8), patient (8), how (8), not (8), disease (8), guidelines (7), transplant (7), when (7), blog (7), nephtrials (7), after (7), mercuri (7), you (6), about (6), please (6), dialysis (6), igan (6), aki (6), have (6), edition (6), why (6), platform (6), cardiovascular (6), therapy (6), surgery (6), but (6), urine (6), output (6), podcasts (5), iga (5), kdigo (5), book (5), world (5), renal (5), which (5), track (5), instagram (5), soda (5), bic (5), resumen (5), advanced (5), beyond (5), sglt2 (5), inhibitors (5), study (5), nephropathy (5), internship (4), your (4), all (4), live (4), abstracts (4), hypertension (4), new (4), atacicept (4), tenposts (4), summary (4), out (4), change (4), 2022 (4), 2024 (4), based (4), into (4), cluster (4), rcts (4), clinical (4), outcomes (4), steps (4), abstract (4), rivaroxaban (4), benefits (4), prevent (4), finerenone (4), egfr (4), non (4), evidence (4), reports (4), dapagliflozin (4), cardiac (4), one (4), was (4), hyponatremia (4), congress (4), day (4), top (3), last (3), first (3), newsletter (3), social (3), media (3), editorial (3), studies (3), blogs (3), considerate (3), creators (3), well (3), where (3), due (3), posts (3), immune (3), tolerance (3), story (3), less (3), liberate (3), pegcetacoplan (3), phase (3), featured (3), perspective (3), voice (3), need (3), see (3), medicine (3), uncertain (3), code (3), long (3), lemon (3), trees (3), grow (3), deep (3), pragmatic (3), example (3), conduct (3), role (3), next (3), registry (3), design (3), master (3), spaces (3), does (3), improve (3), events (3), showing (3), albuminuria (3), reduction (3), rather (3), than (3), matters (3), drug (3), just (3), true (3), month (3), data (3), pregnancy (3), shorts (3), intervention (3), push (3), randomized (3), large (3), regarding (3), care (3), houston (3), fish (3), oil (3), whether (3), journal (3), back (2), thank (2), sign (2), email (2), address (2), name (2), chats (2), keep (2), down (2), subscribe (2), winners (2), kidneys (2), interview (2), experiment (2), conference (2), coverage (2), simultaneously (2), published (2), blogging (2), conferences (2), phosphate (2), targets (2), acc (2), aha (2), chimerism (2), protein (2), supplementation (2), life (2), origin (2), actually (2), catalyst (2), feature (2), flow (2), these (2), now (2), notes (2), joshua (2), perry (2), wilson (2), doesn (2), water (2), zoulfa (2), katouh (2), medical (2), chat (2), let (2), take (2), dive (2), between (2), run (2), periods (2), achieve (2), h4rt (2), lifecycle (2), anchoring (2), swift (2), has (2), number (2), protect (2), captivate (2), missed (2), opportunities (2), equitable (2), access (2), redesign (2), pathway (2), some (2), its (2), team (2), most (2), results (2), here (2), recent (2), post (2), although (2), vascular (2), inflammation (2), thrombosis (2), heart (2), damage (2), anticoagulants (2), previously (2), shown (2), cvd (2), right (2), extends (2), slower (2), decline (2), sustained (2), while (2), modest (2), effects (2), remain (2), opens (2), door (2), broader (2), nsmras (2), raises (2), important (2), questions (2), combination (2), ing (2), sodabic (2), icu (2), acidosis (2), driven (2), multiple (2), overlapping (2), mechanisms (2), bicarbonate (2), infusion (2), supported (2), robust (2), persist (2), mainly (2), habit (2), physiology (2), buffering (2), without (2), benefit (2), cuts (2), postoperative (2), headline (2), result (2), mostly (2), creatinine (2), easily (2), swayed (2), anesthesia (2), fluid (2), shifts (2), vasopressors (2), diuretic (2), mix (2), until (2), shows (2), protects (2), function (2), too (2), sweet (2), prophylactic (2), before (2), discussions (2), iptacopan (2), proteinuria (2), get (2), beta (2), hide (2), hemodialysis (2), years (2), nitrate (2), introducing (2), fix (2), sodium (2), carla (2), nester (2), latest (2), control (2), editors (2), cover (2), simultaneous (2), publication (2), covers (2), lbcts (2), treat (2), immunosuppression (2), restrict (2), supplement (2), analysis (2), flozination (2), origin3 (2), inhibitor (2), chance (2), recover (2), stories (2), valiant (2), potcast (2), anemia (2), management (2), autologous (2), cell (2), react (2), targeted (2), case (2), risk (2), vasculitis (2), signal (2), population (2), trpc6 (2), fsgs (2), health (2), 2027 (2), obinutuzumab (2), membranous (2), seminars (2), covid19 (2), masthead (2), who (2), primer (2), organization (2), articulos (2), channel (2), enthusiasm (2), freely (2), filtered (2), flozinator (2), merch (2), captopril, com, search, nsmc, respect, privacy, receive, weekly, announcing, abreast, going, nephjckidneys, vote, begins, sunday, morning, during, graduation, were, revealed, award, undocumented, immigrant, experience, diaries, achieving, quality, interim, pisces, trying, c3gn, rilparencel, tweetorials, dapackd, dapa, kevin, fowler, innovative, treatments, accessible, communities, means, times, atul, gawande, being, mortal, 2015, eric, topol, 2016, vanessa, grubb, hundreds, interlaced, fingers, 2017, siddhartha, mukherjee, laws, field, science, 2018, andrew, bomback, doctor, object, lessons, 2019, rana, awdish, shock, 2020, mezrich, death, becomes, surgeon, walter, isaacson, breaker, jennifer, doudna, gene, editing, future, human, race, works, abraham, verghese, covenant, john, green, everything, tuberculosis, every, summer, way, through, interest, join, specific, anchor, bridging, gap, efficacy, effectiveness, consent, analyse, interpret, using, dial, mag, creativity, counting, try, having, them, convection, hemodiafiltration, ongoing, efficiency, getting, bewildering, protocols, comprising, umbrella, basket, drugs, meet, protocol, importance, pros, proms, prems, breaking, discord, goals, traditional, beat, calci, interesting, features, beating, calciphylaxis, adaptive, preventing, covid, infections, vulnerable, populations, renalism, single, shots, strategy, reframing, playbook, year, injected, statistical, muscle, then, volunteered, create, cogent, explainers, various, techniques, routinely, described, methods, section, skip, over, rush, manasi, bapat, laurie, tomlinson, know, statistics, desafía, forma, que, utilizamos, los, isglt2, challenge, sglt2i, operative, archive, topics, four, decreases, short, dialyzable, blockers, showed, lower, mace, observational, shaped, regional, prescribing, habits, confounding, factors, end, blocker, debate, aiming, test, feasibility, administration, pregnant, women, dietary, describing, initiative, time, ff93, interventional, valient, ff94, glomerulopathy, stones, ff95, real, good, episodes, twice, aspirational, promise, filtrate, jennie, lin, joel, topf, jordy, cohen, waitzman, nayan, arora, sophia, ambruso, swapnil, hiremath, sit, recap, takes, give, listen, corticosteroid, tapering, steroid, sensitive, podocytopathy, int, rep, prabhahar, 9pm, est, controlled, language, model, assisted, diagnostic, accuracy, bentegeac, scheduled, tentative, schedule, depending, whims, work, group, upcoming, nephjcs, situation, general, news, guideline, update, wow, eight, flown, detect, toolkit, help, vital, original, unbiased, source, education, fall, pledge, drive, creating, chimeras, induce, potential, decrease, eliminate, recipients, says, goodbye, old, dilemma, proteins, premise, pendulum, shift, supportive, structured, fresh, press, already, aging, gracefully, surrogate, outcome, remission, additional, confidence, gbd, meta, chw, hispanic, latino, much, sibeprenlimab, balcinrenone, nejm, lancet, plus, couple, other, kidneywk, baff, attacking, holy, mackerel, maintenance, could, thing, bends, curve, mortality, red, herring, big, catch, empty, net, comes, discontinuing, dialyze, rich, successful, impressed, audience, c3g, mpgn, effort, combat, complement, disorders, cardiology, potassium, belongs, pop, arrhythmia, drop, aim, infinite, allograft, lifespan, infiniti, fifth, pillar, hit, challenging, reflexive, responses, hospital, correcting, searchin, lost, shaker, salt, treatment, cohort, needed, move, past, decades, scattered, clarify, hydralazine, associated, rare, noise, only, scale, reveal, level, finally, bring, paradox, focus, dralazine, induced, 764198, early, podocyte, set, against, small, numbers, heterogeneity, methodological, trade, offs, frame, direction, finding, definitive, inhibition, trick, bundled, featuring, intensive, home, monitoring, coaching, audit, feedback, overcome, poverty, inertia, fragmented, blood, pressure, low, income, receiving, federally, qualified, centers, making, impact, pills, alone, won, win, war, brand, class, largest, series, biopsies, diabetes, diabetics, ready, outperform, tacrolimus, primary, heir, throne, majesty, uses, research, editorials, driving, forward, found,

Text of the page (random words):
usiasm more club de articulos code of conduct the why when and how the nephjc organization twitter journal club primer who are we masthead covid19 seminars in nephrology regarding twitter newsletter shorts merch flozinator blog podcasts freely filtered channel your enthusiasm more club de articulos code of conduct the why when and how the nephjc organization twitter journal club primer who are we masthead covid19 seminars in nephrology regarding twitter newsletter no results found nephjc is a nephrology journal club that uses social media to discuss the research guidelines and editorials that are driving nephrology forward the latest nephjc chat august 17 2026 too sweet to be true prophylactic sglt2 inhibitors before cardiac surgery august 17 2026 mercuri 2 reports that dapagliflozin cuts postoperative aki after cardiac surgery but the headline result is mostly a urine output story not a creatinine one that matters urine output after surgery is easily swayed by anesthesia fluid shifts vasopressors and a diuretic drug in the mix until dapagliflozin shows it protects kidney function not just urine output read more august 17 2026 august 3 2026 buffering without benefit the soda bic study august 3 2026 this week we will discuss sodabic trial with icu acidosis driven by multiple overlapping mechanisms is bicarbonate infusion supported by robust evidence or does it persist mainly out of habit rather than physiology read more august 3 2026 july 20 2026 beyond diabetic kidney disease find ing finerenone s next role july 20 2026 find ckd extends finerenone beyond diabetic kidney disease showing slower egfr decline and sustained albuminuria reduction in non diabetic ckd while the benefits are modest and cardiovascular effects remain uncertain the trial opens the door to broader use of nsmras and raises important questions about combination therapy with sglt2 inhibitors read more july 20 2026 july 6 2026 on the right track rivaroxaban to prevent cardiovascular events in advanced ckd july 6 2026 can rivaroxaban improve cardiovascular outcomes in patients with advanced ckd although vascular inflammation and thrombosis are at the heart of cv damage anticoagulants have not previously shown benefits in cvd patients read more july 6 2026 june 21 2026 heir to the throne obinutuzumab in the membranous nephropathy majesty trial june 21 2026 this week nephjc will discuss whether obinutuzumab is ready to outperform tacrolimus in primary membranous nephropathy read more june 21 2026 june 1 2026 is all kidney disease in diabetics diabetic nephropathy june 1 2026 in this edition of nephjc we discuss the largest case series of kidney biopsies in patients with diabetes read more june 1 2026 may 28 2026 nephjc internship 2026 2027 may 28 2026 introducing nephjc s brand new editorial internship class of 2026 2027 read more may 28 2026 may 18 2026 making an impact on bp why pills alone won t win the war may 18 2026 this week we will discuss whether a bundled team based hypertension intervention featuring intensive bp targets home monitoring health coaching and audit feedback can overcome poverty clinical inertia and fragmented care to improve blood pressure control in low income patients receiving care at federally qualified health centers read more may 18 2026 may 4 2026 is trpc6 inhibition for fsgs a trick or a treat may 4 2026 this week we will discuss a phase 2 trial of the trpc6 inhibitor bi 764198 in fsgs an early signal for a podocyte targeted therapy showing proteinuria reduction but set against small numbers heterogeneity and methodological trade offs that frame this as direction finding rather than definitive evidence read more may 4 2026 april 20 2026 why dralazine population risk of drug induced vasculitis april 20 2026 this week we will discuss why a large registry cohort was needed to move past decades of scattered case reports and clarify the true risk of hydralazine associated vasculitis when rare events hide in noise only scale can reveal the signal can population level data finally bring this paradox into focus read more april 20 2026 april 7 2026 from missed opportunities to equitable access can steps redesign the kidney transplant pathway april 7 2026 summary of the steps trial which will be a twitter spaces discussion read more april 7 2026 april 6 2026 searchin for my lost shaker of salt targeted treatment of hyponatremia april 6 2026 this week we will discuss the hit trial a large randomized study challenging one of the most reflexive responses in hospital medicine see hyponatremia fix the sodium but what if correcting the number doesn t change what actually matters read more april 6 2026 march 30 2026 nephjc covers lbcts at the world congress march 30 2026 the nephjc editors cover the simultaneous publication from the world congress read more march 30 2026 march 9 2026 is react renal autologous cell therapy the fifth pillar in diabetic kidney disease march 9 2026 this week we will discuss the use of renal autologous cell therapy react in diabetic kidney disease read more march 9 2026 february 23 2026 2026 kdigo anemia management guidelines february 23 2026 this week we will discuss 2026 kdigo anemia management in patients with kidney disease read more february 23 2026 february 8 2026 to infiniti and beyond sglt2 inhibitors in kidney transplant patients february 8 2026 this week we aim for an infinite allograft lifespan or flozination in kidney transplant read more february 8 2026 january 26 2026 potcast k pop and arrhythmia drop january 26 2026 this week we will discuss the potcast trial it is a cardiology trial but potassium belongs to nephrology read more january 26 2026 january 11 2026 a valiant effort to combat complement disorders with pegcetacoplan january 11 2026 this week we will discuss the valiant study pegcetacoplan in c3g and ic mpgn read more january 11 2026 january 3 2026 top stories in nephrology 2025 january 3 2026 2025 was rich in successful stories here are the top 10 that impressed our audience read more january 3 2026 december 15 2025 dialyze less recover more aki s chance to get liberate d december 15 2025 this week we will discuss whether less is more when it comes to discontinuing dialysis in patients with aki and a chance to recover read more december 15 2025 december 1 2025 fish oil in dialysis a big catch or an empty net december 1 2025 holy mackerel this week we will discuss fish oil use in maintenance hemodialysis patients could this be the one thing that bends the curve on cv mortality or is it just a red herring read more december 1 2025 november 18 2025 attacking the origin of igan origin3 and atacicept november 18 2025 this week we will discuss the phase 3 origin3 trial of atacicept an april baff inhibitor for use in igan read more november 18 2025 november 8 2025 kidney week in houston day 3 november 8 2025 day 3 of kidney week sibeprenlimab and balcinrenone on nejm and lancet plus a couple of other non kidneywk studies read more november 8 2025 november 8 2025 kidney week in houston day 2 november 8 2025 in this edition fish oil gbd flozination meta analysis chw intervention in hispanic latino patients and much more read more november 8 2025 november 7 2025 kidney week in houston day 1 november 7 2025 in this edition atacicept in igan albuminuria as a surrogate outcome renal remission and additional confidence analysis read more november 7 2025 october 27 2025 2025 igan kdigo guidelines fresh out of press already aging gracefully october 27 2025 this week we will discuss the 2025 kdigo igan guidelines which the shift from supportive care to structured evidence based therapy read more october 27 2025 october 13 2025 the protein pendulum in ckd supplement or restrict october 13 2025 this week we will discuss an old dilemma in nephrology to restrict or supplement the proteins premise advanced ckd and dialysis read more october 13 2025 september 28 2025 chimerism and immune tolerance can we says goodbye to immunosuppression september 28 2025 this week we will discuss the use of creating chimeras to induce immune tolerance and its potential to decrease or eliminate the need for immunosuppression in kidney transplant recipients read more september 28 2025 september 21 2025 nephjc 2025 fall pledge drive september 21 2025 help keep nephjc a vital original and unbiased source of medical education read more september 21 2025 september 15 2025 prevent detect treat what s new in the 2025 hypertension toolkit september 15 2025 this week we will discuss the aha acc 2025 hypertension guideline update wow have eight years flown by read more september 15 2025 news the nephjc that was pregnancy outcomes after aki credit where credit is due please use our visual abstracts blogs and podcasts please be considerate and credit the creators as well read more regarding the situation with social media in general read more live blogging trials from conferences an interview about our experiment with conference coverage of simultaneously published studies read more nephjc covers lbcts at the world congress the nephjc editors cover the simultaneous publication from the world congress read more upcoming nephjcs all scheduled chats are tentative we may change the schedule depending on the whims of the nephjc work group september 1 2026 randomized controlled trial of large language model assisted diagnostic accuracy in nephrology bentegeac r et al ki reports 2026 september 15 2026 book club as long as the lemon trees grow by zoulfa katouh with live twitter discussion 9pm est september 29 2026 randomized control trial of corticosteroid tapering in steroid sensitive podocytopathy prabhahar a et al kidney int rep twice a month that s aspirational not a promise the filtrate jennie lin joel topf jordy cohen joshua waitzman nayan arora sophia ambruso and swapnil hiremath sit down and recap the latest nephjc discussion we go as deep as it takes give it a listen how to subscribe episodes august 23 2026 ff95 the push trial push it real good august 23 2026 push water to prevent kidney stones or not read more august 23 2026 july 17 2026 ff94 c3 glomerulopathy with carla nester july 17 2026 the valient trial with carla nester read more july 17 2026 june 30 2026 ff93 hyponatremia interventional trial june 30 2026 time to fix the sodium the hyponatremia intervention trial read more june 30 2026 introducing nephjc shorts see the blog post describing this initiative featured august 25 2026 dietary nitrate supplementation in ckd pregnancy august 25 2026 first trial in pregnancy and ckd after 30 years aiming to test feasibility of nitrate administration in pregnant women with ckd read more august 25 2026 august 21 2026 is this the end of the beta blocker debate in hemodialysis august 21 2026 non dialyzable beta blockers showed lower mace but the study was observational and shaped by regional prescribing habits that may hide confounding factors read more august 21 2026 august 11 2026 nephjc short 24 month iptacopan egfr data in iga nephropathy august 11 2026 iptacopan decreases proteinuria now we get the 24 month egfr data in patients with iga nephropathy read more august 11 2026 recent discussions last four nephjc discussions august 17 2026 too sweet to be true prophylactic sglt2 inhibitors before cardiac surgery august 17 2026 mercuri 2 reports that dapagliflozin cuts postoperative aki after cardiac surgery but the headline result is mostly a urine output story not a creatinine one that matters urine output after surgery is easily swayed by anesthesia fluid shifts vasopressors and a diuretic drug in the mix until dapagliflozin shows it protects kidney function not just urine output read more august 17 2026 august 10 2026 credit where credit is due august 10 2026 please use our visual abstracts blogs and podcasts please be considerate and credit the creators as well read more august 10 2026 august 3 2026 nephjc book club 2026 as long as the lemon trees grow august 3 2026 read more august 3 2026 august 3 2026 buffering without benefit the soda bic study august 3 2026 this week we will discuss sodabic trial with icu acidosis driven by multiple overlapping mechanisms is bicarbonate infusion supported by robust evidence or does it persist mainly out of habit rather than physiology read more august 3 2026 july 20 2026 beyond diabetic kidney disease find ing finerenone s next role july 20 2026 find ckd extends finerenone beyond diabetic kidney disease showing slower egfr decline and sustained albuminuria reduction in non diabetic ckd while the benefits are modest and cardiovascular effects remain uncertain the trial opens the door to broader use of nsmras and raises important questions about combination therapy with sglt2 inhibitors read more july 20 2026 july 6 2026 on the right track rivaroxaban to prevent cardiovascular events in advanced ckd july 6 2026 can rivaroxaban improve cardiovascular outcomes in patients with advanced ckd although vascular inflammation and thrombosis are at the heart of cv damage anticoagulants have not previously shown benefits in cvd patients read more july 6 2026 archive of all nephjc topics visual abstracts featured august 17 2026 mercuri 2 the visual abstract august 17 2026 does mercuri 2 challenge how we use sglt2i in post operative patients read more august 17 2026 august 3 2026 soda bic the visual abstract august 3 2026 read more august 3 2026 july 17 2026 find ckd the visual abstract july 17 2026 read more july 17 2026 july 6 2026 track the visual abstract july 6 2026 read more july 6 2026 resumen visual blog mercuri 2 el resumen visual mercuri 2 desafía la forma en que utilizamos los isglt2 read more soda bic el resumen visual read more find ckd el resumen visual read more track el resumen visual read more nephjc on instagram blog august 17 2026 mercuri 2 on instagram august 17 2026 read more august 17 2026 august 10 2026 soda bic on instagram august 10 2026 read more august 10 2026 august 10 2026 find ckd trial on instagram august 10 2026 read more august 10 2026 august 10 2026 track trial on instagram august 10 2026 read more august 10 2026 what you need to know about statistics in the last year nephjc has injected some statistical muscle into its editorial team thank you perry wilson and laurie tomlinson then manasi bapat volunteered to create some cogent explainers for the various techniques that are routinely described in the methods section most of us skip over as we rush to the results here are the recent posts blog april 7 2026 from missed opportunities to equitable access can steps redesign the kidney transplant pathway april 7 2026 summary of the steps trial which will be a twitter spaces discussion read more april 7 2026 june 25 2025 from single shots to strategy how captivate is reframing the nephtrials playbook june 25 2025 summary of the captivate platform which will be a twitter spaces discussion read more june 25 2025 march 10 2024 the protect v platform renalism no more march 10 2024 ...